SAN FRANCISCO (GenomeWeb News) – Caliper Life Sciences is working on developing its technologies for future uses in molecular diagnostics and front-end sample preparation for next-generation sequencing systems.

Those opportunities are two of three major initiatives in the firm's pipeline, President and CEO Kevin Hrusovsky said Thursday at the JPMorgan Healthcare Conference held here. The company also is working on a new, integrated molecular biology workstation.
But key future revenue drivers could come in the form of the sequencing sample prep and MDx instruments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.